F. Cham

发表

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens

V. Colizzi, C. Perno, S. Billong, 2020, Antimicrobial Resistance & Infection Control.

Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.

L. Morris, A. Sönnerborg, F. Maldarelli, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8.

H. Whittle, S. Jaffar, R. Weiss, 1998, Journal of human virology.

In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4+ T-cell activation/ exhaustion

C. Fletcher, S. Byrareddy, B. Bagaya, 2021, BMC Complementary Medicine and Therapies.

Development of a one-tube multiplex reverse transcriptase-polymerase chain reaction assay for the simultaneous amplification of HIV type 1 group M gag and env heteroduplex mobility assay fragments.

H. Whittle, S. Coppens, G. Van der Auwera, 2000, AIDS research and human retroviruses.

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

F. Ceccherini‐Silberstein, C. Perno, V. Colizzi, 2021, HIV medicine.

The World Health Organization African region external quality assessment scheme for anti-HIV serology

Adrian Puren, A. Puren, Fatim Cham, 2011, African journal of laboratory medicine.

Etiology and Antimicrobial Susceptibility of Pathogens Responsible for Urethral Discharge Among Men in Harare, Zimbabwe

P. Mason, S. Takuva, D. Lewis, 2014, Sexually transmitted diseases.

Identification of Acute HIV-1 Infection by Hologic Aptima HIV-1 RNA Qualitative Assay

S. Peel, L. Jagodzinski, M. Robb, 2017, Journal of Clinical Microbiology.

Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.

S. Rybak, C. Broder, J. Louis, 2007, Virology.

HIV‐2-specific cytotoxic T‐lymphocyte activity is inversely related to proviral load

H. Whittle, S. Jaffar, K. Ariyoshi, 1995, AIDS.

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study

M. Robb, A. Esber, L. Eller, 2019, PloS one.

Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low- and middle-income countries.

S. Ávila-Ríos, S. Billong, D. Ssemwanga, 2020, AIDS.

The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region.

Clement Zeh, John N Nkengasong, Tsehaynesh Messele, 2010, American journal of clinical pathology.

Human Immunodeficiency Virus Type 1 Clades Patients Frequently Cross-React with Different Immunodeficiency Virus Type 2-Infected Cytotoxic T Cells from Human

S. Rowland-Jones, H. Whittle, T. Rostron, 2014 .

Cytotoxic T Cells from Human Immunodeficiency Virus Type 2-Infected Patients Frequently Cross-React with Different Human Immunodeficiency Virus Type 1 Clades

H. Whittle, K. Ariyoshi, A. Bertoletti, 1998, Journal of Virology.

Identiﬁcation and Characterization of a New Cross-Reactive Human Immunodeﬁciency Virus Type 1-Neutralizing Human Monoclonal Antibody

Dennis R. Burton, Xiaodong Xiao, Peter Bouma, 2022 .

Quantification of Human T-lymphotropic virus type I (HTLV-I) provirus load in a rural West African population: no enhancement of human immunodeficiency virus type 2 pathogenesis, but HTLV-I provirus load relates to mortality.

H. Whittle, S. Jaffar, K. Ariyoshi, 2003, The Journal of infectious diseases.

Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.

D. Bennett, T. Apollo, O. Mugurungi, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization

C. Broder, Y. Shao, N. Mathy, 2007, Proceedings of the National Academy of Sciences.

Brief Report: Differential Associations of Interleukin 6 and Intestinal Fatty Acid-Binding Protein With Progressive Untreated HIV-1 Infection in Rakai, Uganda

T. Quinn, M. Robb, R. Gray, 2016, Journal of acquired immune deficiency syndromes.

Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.

H. Katinger, James E. Robinson, L. Heyndrickx, 2006, Virology.

Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library.

S. Rybak, C. Broder, D. Dimitrov, 2003, Journal of immunological methods.

Does HIV-2 infection provide cross-protection against HIV-1 infection?

H. Whittle, T. Corrah, F. Cham, 1997, AIDS.

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study

M. Robb, A. Esber, L. Eller, 2019, PloS one.

Diagnosis of HIV-1/2 dual infection using dilution analysis of type-specific antibody.

H. Whittle, R. Tedder, K. Ariyoshi, 1998, AIDS.